Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Microbiome Drugs Market Report, History and Forecast 2016-2027

Published by QYResearch Product code 1019029
Published Content info 99 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Microbiome Drugs Market Report, History and Forecast 2016-2027
Published: July 19, 2021 Content info: 99 Pages
Description

Market Analysis and Insights:

The research report studies the Microbiome Drugs market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Microbiome Drugs market size is projected to reach US$ 1324.15 million by 2027, from US$ 193.16 million in 2020, at a CAGR of 34.64% during 2021-2027.

Scope and Segment:

The global Microbiome Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

By Company

  • Pfizer
  • Second Genome
  • Seres Therapeutics
  • MaaT Pharma
  • Enterome Bioscience
  • Microbiome Drugs
  • Ritter Pharmaceuticals
  • Rebiotix
  • OpenBiome

Segment by Type

  • Oral Dosage Form
  • Enteric Capsules
  • Others

Segment by Application

  • Gastrointestinal Disorders
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Others

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • South America
    • Brazil
  • Middle East & Africa
    • Middle East
    • Africa
Table of Contents

TABLE OF CONTENTS

1 MARKET OVERVIEW OF MICROBIOME DRUGS

  • 1.1 Microbiome Drugs Market Overview
    • 1.1.1 Microbiome Drugs Product Scope
    • 1.1.2 Microbiome Drugs Market Status and Outlook
  • 1.2 Global Microbiome Drugs Market Size Overview by Region 2016 VS 2021 VS 2027
  • 1.3 Global Microbiome Drugs Market Size by Region (2016-2027)
  • 1.4 Global Microbiome Drugs Historic Market Size by Region (2016-2021)
  • 1.5 Global Microbiome Drugs Market Size Forecast by Region (2022-2027)
  • 1.6 Key Regions Microbiome Drugs Market Size (2016-2027)
    • 1.6.1 North America Microbiome Drugs Market Size (2016-2027)
    • 1.6.2 Europe Microbiome Drugs Market Size (2016-2027)
    • 1.6.3 Asia-Pacific Microbiome Drugs Market Size (2016-2027)
    • 1.6.4 South America Microbiome Drugs Market Size (2016-2027)
    • 1.6.5 Middle East & Africa Microbiome Drugs Market Size (2016-2027)

2 MICROBIOME DRUGS MARKET OVERVIEW BY TYPE

  • 2.1 Global Microbiome Drugs Market Size by Type: 2016 VS 2021 VS 2027
  • 2.2 Global Microbiome Drugs Historic Market Size by Type (2016-2021)
  • 2.3 Global Microbiome Drugs Forecasted Market Size by Type (2022-2027)
  • 2.4 Oral Dosage Form
  • 2.5 Enteric Capsules

3 MICROBIOME DRUGS MARKET OVERVIEW BY APPLICATION

  • 3.1 Global Microbiome Drugs Market Size by Application: 2016 VS 2021 VS 2027
  • 3.2 Global Microbiome Drugs Historic Market Size by Application (2016-2021)
  • 3.3 Global Microbiome Drugs Forecasted Market Size by Application (2022-2027)
  • 3.4 Gastrointestinal Disorders
  • 3.5 Diabetes
  • 3.6 Autoimmune Disorders
  • 3.7 Cancer

4 MICROBIOME DRUGS COMPETITION ANALYSIS BY PLAYERS

  • 4.1 Date of Key Players Enter into Microbiome Drugs Market
  • 4.2 Global Top Players Microbiome Drugs Headquarters and Area Served
  • 4.3 Key Players Microbiome Drugs Product Solution and Service
  • 4.4 Global Major Microbiome Drugs Developer Application
  • 4.5 Mergers & Acquisitions, Expansion Plans

5 ANALYSIS OF MICROBIOME DRUGS INDUSTRY KEY MANUFACTURERS

  • 5.1 Seres Therapeutics
    • 5.1.1 Company Profile
    • 5.1.2 Product Information
  • 5.2 Assembly Biosciences
    • 5.2.1 Company Profile
    • 5.2.2 Product Information
  • 5.3 Synthetic Biologics
    • 5.3.1 Company Profile
    • 5.3.2 Product Information
  • 5.4 Interxon
    • 5.4.1 Company Profile
    • 5.4.2 Product Information
  • 5.5 PureTech
    • 5.5.1 Company Profile
    • 5.5.2 Product Information
  • 5.6 Synlogic
    • 5.6.1 Company Profile
    • 5.6.2 Product Information
  • 5.7 Enterome BioScience
    • 5.7.1 Company Profile
    • 5.7.2 Product Information
  • 5.8 4D Pharma
    • 5.8.1 Company Profile
    • 5.8.2 Product Information
  • 5.9 Second Genome
    • 5.9.1 Company Profile
    • 5.9.2 Product Information
  • 5.10 AOBiome
    • 5.10.1 Company Profile
    • 5.10.2 Product Information
  • 5.11 Rebiotix
    • 5.11.1 Company Profile
    • 5.11.2 Product Information
  • 5.12 Metabiomics
    • 5.12.1 Company Profile
    • 5.12.2 Product Information
  • 5.13 Ritter Pharmaceuticals
    • 5.13.1 Company Profile
    • 5.13.2 Product Information
  • 5.14 Symberix
    • 5.14.1 Company Profile
    • 5.14.2 Product Information
  • 5.15 OpenBiome
    • 5.15.1 Company Profile
    • 5.15.2 Product Information
  • 5.16 Azitra
    • 5.16.1 Company Profile
    • 5.16.2 Product Information
  • 5.17 Osel
    • 5.17.1 Company Profile
    • 5.17.2 Product Information

6 NORTH AMERICA

  • 6.1 North America Microbiome Drugs Market Size by Country (2016-2027)
  • 6.2 United States
  • 6.3 Canada
  • 6.4 Mexico

7 EUROPE

  • 7.1 Europe Microbiome Drugs Market Size by Country (2016-2027)
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Microbiome Drugs Market Size by Region (2016-2027)
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia

9 SOUTH AMERICA

  • 9.1 South America Microbiome Drugs Market Size by Country (2016-2027)
  • 9.2 Brazil

10 MIDDLE EAST & AFRICA

  • 10.1 Middle East & Africa Microbiome Drugs Market Size by Country
  • 10.2 Middle East
  • 10.3 Africa

11 MICROBIOME DRUGS MARKET DYNAMICS

  • 11.1 Microbiome Drugs Industry Trends
  • 11.2 Microbiome Drugs Market Drivers
  • 11.3 Microbiome Drugs Market Challenges
  • 11.4 Microbiome Drugs Market Restraints

12 RESEARCH FINDING/CONCLUSION

13 METHODOLOGY AND DATA SOURCE

  • 13.1 Methodology/Research Approach
    • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
  • 13.3 Disclaimer
  • 13.4 Author List

List of Tables and Figures

  • Table 1. Global Market Microbiome Drugs Market Size (US$ Million) Comparison by Region: 2016 VS 2021 VS 2027
  • Table 2. Global Microbiome Drugs Market Size by Region (2016-2021) & (US$ Million)
  • Table 3. Global Microbiome Drugs Market Size Share by Region (2016-2021)
  • Table 4. Global Microbiome Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million)
  • Table 5. Global Microbiome Drugs Forecasted Market Size Share by Region (2022-2027)
  • Table 6. Global Microbiome Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
  • Table 7. Global Microbiome Drugs Market Size by Type (2016-2021) & (US$ Million)
  • Table 8. Global Microbiome Drugs Revenue Market Share by Type (2016-2021)
  • Table 9. Global Microbiome Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million)
  • Table 10. Global Microbiome Drugs Revenue Market Share by Type (2022-2027)
  • Table 11. Global Microbiome Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
  • Table 12. Global Microbiome Drugs Market Size by Application (2016-2021) & (US$ Million)
  • Table 13. Global Microbiome Drugs Revenue Market Share by Application (2016-2021)
  • Table 14. Global Microbiome Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million)
  • Table 15. Global Microbiome Drugs Revenue Market Share by Application (2022-2027)
  • Table 16. Date of Key Players Enter into Microbiome Drugs Market
  • Table 17. Global Microbiome Drugs Top Players Headquarters and Area Served
  • Table 18. Microbiome Drugs Product Solution and Service
  • Table 19. Global Major Microbiome Drugs Developer Application
  • Table 20. Mergers & Acquisitions, Expansion Plans
  • Table 21. Seres Therapeutics Company Profile
  • Table 22. Microbiome Drugs Product Information of Seres Therapeutics
  • Table 23. Assembly Biosciences Company Profile
  • Table 24. Microbiome Drugs Product Information of Assembly Biosciences
  • Table 25. Synthetic Biologics Company Profile
  • Table 26. Microbiome Drugs Product Information of Synthetic Biologics
  • Table 27. Interxon Company Profile
  • Table 28. Microbiome Drugs Product Information of Interxon
  • Table 29. PureTech Company Profile
  • Table 30. Microbiome Drugs Product Information of PureTech
  • Table 31. Synlogic Company Profile
  • Table 32. Microbiome Drugs Product Information of Synlogic
  • Table 33. Enterome BioScience Company Profile
  • Table 34. Microbiome Drugs Product Information of Enterome BioScience
  • Table 35. 4D Pharma Company Profile
  • Table 36. Microbiome Drugs Product Information of 4D Pharma
  • Table 37. Second Genome Company Profile
  • Table 38. Microbiome Drugs Product Information of Second Genome
  • Table 39. AOBiome Company Profile
  • Table 40. Microbiome Drugs Product Information of AOBiome
  • Table 41. Rebiotix Company Profile
  • Table 42. Microbiome Drugs Product Information of Rebiotix
  • Table 43. Metabiomics Company Profile
  • Table 44. Microbiome Drugs Product Information of Metabiomics
  • Table 45. Ritter Pharmaceuticals Company Profile
  • Table 46. Microbiome Drugs Product Information of Ritter Pharmaceuticals
  • Table 47. Symberix Company Profile
  • Table 48. Microbiome Drugs Product Information of Symberix
  • Table 49. OpenBiome Company Profile
  • Table 50. Microbiome Drugs Product Information of OpenBiome
  • Table 51. Azitra Company Profile
  • Table 52. Microbiome Drugs Product Information of Azitra
  • Table 53. Osel Company Profile
  • Table 54. Microbiome Drugs Product Information of Osel
  • Table 55. North America Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
  • Table 56. North America Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
  • Table 57. Europe Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
  • Table 58. Europe Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
  • Table 59. Europe Microbiome Drugs Market Share by Country (2016-2021)
  • Table 60. Europe Microbiome Drugs Market Share by Country (2022-2027)
  • Table 61. Asia-Pacific Microbiome Drugs Market Size by Region (2016-2021) & (US$ Million)
  • Table 62. Asia-Pacific Microbiome Drugs Market Size by Region (2022-2027) & (US$ Million)
  • Table 63. Asia-Pacific Microbiome Drugs Market Share by Region (2022-2027)
  • Table 64. South America Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
  • Table 65. South America Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
  • Table 66. Middle East & Africa Microbiome Drugs Market Size by Country (2016-2021) & (US$ Million)
  • Table 67. Middle East & Africa Microbiome Drugs Market Size by Country (2022-2027) & (US$ Million)
  • Table 68. Microbiome Drugs Market Trends
  • Table 69. Microbiome Drugs Market Drivers
  • Table 70. Microbiome Drugs Market Challenges
  • Table 71. Microbiome Drugs Market Restraints
  • Table 72. Research Programs/Design for This Report
  • Table 73. Key Data Information from Secondary Sources
  • Table 74. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Microbiome Drugs Market Size Year-over-Year 2016-2027 & (US$ Million)
  • Figure 2. Global Microbiome Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 3. Global Microbiome Drugs Market Share by Region: 2027
  • Figure 4. Global Microbiome Drugs Forecasted Market Size Share by Region (2022-2027)
  • Figure 5. North America Microbiome Drugs Market Size (US$ Million) Growth Rate (2016-2027)
  • Figure 6. Europe Microbiome Drugs Market Size (US$ Million) and Growth Rate (2016-2021)
  • Figure 7. Asia-Pacific Microbiome Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
  • Figure 8. South America Microbiome Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
  • Figure 9. Middle East & Africa Microbiome Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
  • Figure 10. Global Microbiome Drugs Market Size Share by Type in 2027
  • Figure 11. Oral Dosage Form Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 12. Enteric Capsules Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 13. Global Microbiome Drugs Market Size Share by Application in 2027
  • Figure 14. Gastrointestinal Disorders Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 15. Diabetes Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 16. Autoimmune Disorders Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 17. Cancer Market Size (US$ Million) & YoY Growth (2016-2027)
  • Figure 18. North America Microbiome Drugs Market Share by Country (2016-2027)
  • Figure 19. United States Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 20. Canada Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 21. Mexico Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 22. Germany Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 23. France Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 24. U.K. Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 25. Italy Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 26. Russia Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 27. Asia-Pacific Microbiome Drugs Market Share by Region (2016-2027)
  • Figure 28. China Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 29. Japan Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 30. South Korea Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 31. Southeast Asia Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 32. India Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 33. Australia Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 34. Brazil Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 35. Middle East Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 36. Africa Microbiome Drugs Market Size (2016-2027) & (US$ Million)
  • Figure 37. Bottom-up and Top-down Approaches for This Report
  • Figure 38. Data Triangulation 92
Back to Top